FW: Google Alert - Indian patent office

 

 

From: Google Alerts [mailto:googlealerts-noreply@google.com]
Sent: 31 March 2018 07:31
To: roshan@siddhast.com
Subject: Google Alert - Indian patent office

 

Indian patent office Daily update ⋅ 31 March 2018 NEWS Glivec: The patently David vs Goliath battle Business Line Y K SapruOn April 1, 2013, the Supreme Court rejected Novartis' final appeal for a patent on Imatinib Mesylate (Glivec), a drug that treats chronic myloid luekaemia (CML). The patent application was rejected based on Section 3(d) of India's patent law that prevents ever-greening, that is, patents are not ... Flag as irrelevant Senate Bill Would Immunize Patent Board from Tribal Trickery Bloomberg BNA The U.S. Appeals Court for the Federal Circuit decided this week to fast-track an appeal that will decide whether an American Indian tribe patent holder ... PTAB, part of the Patent and Trademark Office, ruled last month it has authority to address the patents' validity, notwithstanding Allergan's handoff. Flag as irrelevant See more results | Edit this alert   You have received this email because you have subscribed to Google Alerts. Unsubscribe | View all your alerts Receive this alert as RSS feed Send Feedback